⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24755711 | 1.00 | — | — | |
| SCHEMBL24755957 | 1.00 | — | — | |
| SCHEMBL30136672 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL31370937 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL31370958 | 0.98 | — | — | |
| SCHEMBL24756401 | 0.88 | — | — | |
| SCHEMBL24756534 | 0.85 | — | — | |
| SCHEMBL24756062 | 0.85 | — | — | |
| SCHEMBL24755688 | 0.85 | — | — | |
| SCHEMBL30136720 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4611748-A1 | COMBINATION THERAPY FOR TREATING CANCER | Scorpion Therapeutics, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| US-20240300939-A1 | UREA DERIVATIVES WHICH CAN BE USED TO TREAT CANCER | SCORPION THERAPEUTICS, INC. | 2024-09-12 | — | — | US | disclosed |
| WO-2024097636-A1 | COMBINATION THERAPY FOR TREATING CANCER | SCORPION THERAPEUTICS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |
| EP-4334298-A1 | UREA DERIVATIVES WHICH CAN BE USED TO TREAT CANCER | Scorpion Therapeutics, Inc. (US) | 2024-03-13 | — | — | EP | disclosed |
| WO-2022265993-A1 | UREA DERIVATIVES WHICH CAN BE USED TO TREAT CANCER | SCORPION THERAPEUTICS, INC. (US) | 2022-12-22 | — | — | WO | disclosed |